Cysteine Protease inhibitor
产品说明书
 |
同义名 : | - |
| CAS号 : | 921625-62-9 | |
| 货号 : | A812592 | |
| 分子式 : | C18H14N4O | |
| 纯度 : | 95% | |
| 分子量 : | 302.33 | |
| MDL号 : | MFCD00130887 | |
| 存储条件： |
Pure form Inert atmosphere, store in freezer, under -20°C In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 50 mg/mL(165.38 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Cysteine protease inhibitor is an inhibitor of cysteine protease. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00157508 | Type 2 Diabetes ... 展开 >> Early Nephropathy 收起 << | Phase 2 | Terminated | - | Italy ... 展开 >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 收起 << |
| NCT00166166 | Hyperlipidemia | Phase 2 | Terminated(Limited clinical st... 展开 >>aff) 收起 << | - | United States, Georgia ... 展开 >> Emory University School of Medicine Atlanta, Georgia, United States, 30322 收起 << |
| NCT00166166 | - | Terminated(Limited clinical st... 展开 >>aff) 收起 << | - | - | |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
3.31mL 0.66mL 0.33mL |
16.54mL 3.31mL 1.65mL |
33.08mL 6.62mL 3.31mL |
| 参考文献 |
|---|